Social media as a source of drug safety information in the paediatric population
British Journal of Clinical Pharmacology · 2025
DOI: 10.1111/bcp.16392 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift British Journal of Clinical Pharmacology, 2025. Verfasst von Ingrid Vilimelis-Piulats und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of Barcelona (Faculty of Pharmacy and Food Sciences Campus Diagonal), Barcelona, Spain. Hauptthemen laut MEDLINE: Drug-Related Side Effects and Adverse Reactions, Social Media, Pharmacovigilance, Medication Errors. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Aims
The paediatric population is vulnerable to suffering adverse drug events (ADEs) such as negative outcomes due to medication (NOMs)–drug related problems (DRPs), especially adverse drug reactions (ADRs) and medication errors (MEs). Social media (SM) is considered an interesting tool for pharmacovigilance. This study aims to assess descriptions of ADRs, NOM‐DRPs and MEs in SM.
Methods
Observational, ambispective study assessing NOM‐DRPs, ADRs and MEs in posts of child‐rearing public parenting forums from inception until December 2021 of drugs dispensed in outpatient setting. ADEs were classified, assessing causality by Liverpool Causality Assessment Tool and seriousness by the World Health Organization criteria. Summary of product characteristics were used to determine ADR prevalence.
Results
In total, 3573 posts of 2 child‐rearing public parenting forums were retrieved; 906 (25%) contained descriptions of medicine of which 823 (91%) were analysed; 425 posts (52%) described 636 NOM‐DRPs (1 NOM‐DRP median per child, interquartile range [IQR] 1–8), from which 161 (26%) were ADRs in 105 posts (1.5 ADR median per child, IQR 1–4) and 95 (15%) were MEs in 64 posts (1 ME median per child, IQR 1–4). From posts mined with medicines mentions, 70% included NOM‐DRPs, 18% ADRs and 10% MEs. More ADRs occurred in females and infants. Most ADRs (158; 98%) were evaluated as possible and 17 ADRs (11%) were serious. Uncommon 19 (12%), (14, 9%), very rare (3, 2%) and rare (1, 1%) ADRs were also found.
Conclusion
Results suggest that information retrieved from SM may be useful to assess paediatric ADEs and provide valuable pharmacovigilance complementary data.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Barcelona (Faculty of Pharmacy and Food Sciences Campus Diagonal), Barcelona, Spain.
- Hospital Universitari Germans Trias i Pujol (Pharmacy department). Badalona, Barcelona, Spain.
- 2CAT Foundation (Distributed Artificial Intelligence Departament), Barcelona, Spain.
- Hospital Universitari Vall d'Hebron (Pharmacy department). Gestió Clínica del Medicament, Barcelona, Spain.
ORCID-Profile: Ingrid Vilimelis-Piulats
Zitieren
APA
Vilimelis-Piulats, I., Pérez-Ricart, A., Peligero, M. B., Calvo, A., Negre, J. M. S., & Juárez-Gimenez, J. C. (2025). Social media as a source of drug safety information in the paediatric population. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16392
Vancouver
Vilimelis-Piulats I, Pérez-Ricart A, Peligero MB, Calvo A, Negre JMS, Juárez-Gimenez JC. Social media as a source of drug safety information in the paediatric population. British Journal of Clinical Pharmacology. 2025. doi:10.1111/bcp.16392
BibTeX
@article{VilimelisPiulats2025,
author = {Vilimelis-Piulats, Ingrid and Pérez-Ricart, Ariadna and Peligero, Maite Bosch and Calvo, Albert and Negre, Josep Maria Suñé and Juárez-Gimenez, Juan-Carlos},
title = {Social media as a source of drug safety information in the paediatric population},
journal = {British Journal of Clinical Pharmacology},
year = {2025},
doi = {10.1111/bcp.16392}
}
EUVIMED